ReviewCancer management and research2018
Whole-body magnetic resonance imaging for the assessment of metastatic breast cancer.
Review in Cancer management and research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Role of Whole-Body Magnetic Resonance Imaging in Detecting Metastasis in Patients With Known Cancer.Cureus · 2026Article
- Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives.Cancer imaging : the official publication of the International Cancer Imaging Society · 2023Review
- Whole‑body MRI for metastatic workup in patients diagnosed with cancer.Molecular and clinical oncology · 2023Article
- A review on the added value of whole-body MRI in metastatic lobular breast cancer.European radiology · 2022Review
- Imaging diagnosis of metastatic breast cancer.Insights into imaging · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is the most common type of tumor in women and an important cause of mortality in the female population. The early and precise diagnosis, staging, and treatment of this neoplasia are essential for public health purposes. Technological development, for example, of whole-body magnetic resonance imaging, made possible the adoption of new imaging modalities for a better approach for these patients. This imaging modality is helpful to staging, to therapy response assessment, and to the study of therapeutic changes in bone marrow, because it gives, at the same time, anatomical information using T1- and T2-weighted images, with high spatial resolution and tissue contrast, as well as functional sequences (diffusion-weighted images), which make possible the detection of hypercellular viable tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.